Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-Current Assets: 2020-2022

Historic Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $86.6 million.

  • Cullinan Therapeutics' Non-Current Assets fell 48.82% to $18.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $18.0 million, marking a year-over-year decrease of 48.82%. This contributed to the annual value of $86.6 million for FY2022, which is 38.38% down from last year.
  • Cullinan Therapeutics' Non-Current Assets amounted to $86.6 million in FY2022, which was down 38.38% from $140.6 million recorded in FY2021.
  • Over the past 5 years, Cullinan Therapeutics' Non-Current Assets peaked at $140.6 million during FY2021, and registered a low of $2.4 million during FY2020.
  • Over the past 3 years, Cullinan Therapeutics' median Non-Current Assets value was $86.6 million (recorded in 2022), while the average stood at $76.6 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Non-Current Assets skyrocketed by 5,686.87% in 2021 and then tumbled by 38.38% in 2022.
  • Yearly analysis of 3 years shows Cullinan Therapeutics' Non-Current Assets stood at $2.4 million in 2020, then skyrocketed by 5,686.87% to $140.6 million in 2021, then crashed by 38.38% to $86.6 million in 2022.